Gene Ontology (GO)-driven inference of candidate proteomic markers associated with muscle atrophy conditions

Angelique Stalmach, Ines Boehm, Marco Fernandes, Alison Rutter, Richard J.E. Skipworth, Holger Husi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
3 Downloads (Pure)

Abstract

Skeletal muscle homeostasis is essential for the maintenance of a healthy and active lifestyle. Imbalance in muscle homeostasis has significant consequences such as atrophy, loss of muscle mass, and progressive loss of functions. Aging-related muscle wasting, sarcopenia, and atrophy as a consequence of disease, such as cachexia, reduce the quality of life, increase morbidity and result in an overall poor prognosis. Investigating the muscle proteome related to muscle atrophy diseases has a great potential for diagnostic medicine to identify (i) potential protein biomarkers, and (ii) biological processes and functions common or unique to muscle wasting, cachexia, sarcopenia, and aging alone. We conducted a meta-analysis using gene ontology (GO) analysis of 24 human proteomic studies using tissue samples (skeletal muscle and adipose biopsies) and/or biofluids (serum, plasma, urine). Whilst there were few similarities in protein directionality across studies, biological processes common to conditions were identified. Here we demonstrate that the GO analysis of published human proteomics data can identify processes not revealed by single studies. We recommend the integration of proteomics data from tissue samples and biofluids to yield a comprehensive overview of the human skeletal muscle proteome. This will facilitate the identification of biomarkers and potential pathways of muscle-wasting conditions for use in clinics.

Original languageEnglish
Article number5514
JournalMolecules
Volume27
Issue number17
DOIs
Publication statusPublished - 27 Aug 2022

Keywords

  • biomarker
  • cancer cachexia
  • muscle wasting
  • proteomics
  • sarcopenia

Fingerprint

Dive into the research topics of 'Gene Ontology (GO)-driven inference of candidate proteomic markers associated with muscle atrophy conditions'. Together they form a unique fingerprint.

Cite this